Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A non-catalytic scaffolding activity of hexokinase 2 contributes to EMT and metastasis
Catherine Blaha, Gopalakrishnan Ramakrishnan, Sang‐Min Jeon, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Tumor glycolysis, an essential sweet tooth of tumor cells
Sumana Paul, Saikat Ghosh, Sushil Kumar
Seminars in Cancer Biology (2022) Vol. 86, pp. 1216-1230
Closed Access | Times Cited: 184
Hexokinase 2-mediated gene expression via histone lactylation is required for hepatic stellate cell activation and liver fibrosis
Hyunsoo Rho, Alexander R. Terry, Constantinos Chronis, et al.
Cell Metabolism (2023) Vol. 35, Iss. 8, pp. 1406-1423.e8
Open Access | Times Cited: 116
Metabolic heterogeneity in cancer
Margherita Demicco, Xiao‐Zheng Liu, Katharina Leithner, et al.
Nature Metabolism (2024) Vol. 6, Iss. 1, pp. 18-38
Closed Access | Times Cited: 52
HKDC1, a target of TFEB, is essential to maintain both mitochondrial and lysosomal homeostasis, preventing cellular senescence
Mengying Cui, Koji Yamano, Kenichi Yamamoto, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 2
Open Access | Times Cited: 17
Nrf2 Modulation in Breast Cancer
Somayyeh Ghareghomi, Mehran Habibi-Rezaei, Marzia Arese, et al.
Biomedicines (2022) Vol. 10, Iss. 10, pp. 2668-2668
Open Access | Times Cited: 63
CD36 maintains lipid homeostasis via selective uptake of monounsaturated fatty acids during matrix detachment and tumor progression
Alexander R. Terry, Véronique Nogueira, Hyunsoo Rho, et al.
Cell Metabolism (2023) Vol. 35, Iss. 11, pp. 2060-2076.e9
Closed Access | Times Cited: 35
Degradation of Hexokinase 2 Blocks Glycolysis and Induces GSDME-Dependent Pyroptosis to Amplify Immunogenic Cell Death for Breast Cancer Therapy
Ruoxi Sang, Renming Fan, Aohua Deng, et al.
Journal of Medicinal Chemistry (2023) Vol. 66, Iss. 13, pp. 8464-8483
Closed Access | Times Cited: 28
Cancer immunometabolism: advent, challenges, and perspective
Qin Dang, Borui Li, Bing Jin, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 13
Metabolic Signaling in Cancer Metastasis
Sarah Krieg, Sara Fernandes, Constantinos Kolliopoulos, et al.
Cancer Discovery (2024) Vol. 14, Iss. 6, pp. 934-952
Open Access | Times Cited: 12
The Molecular Mechanisms behind Advanced Breast Cancer Metabolism: Warburg Effect, OXPHOS, and Calcium
Erna Mitaishvili, Hanna Feinsod, Zachary David, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 10
Src inhibition potentiates MCL-1 antagonist activity in acute myeloid leukemia
Xiaoyan Hu, Lin Li, Jewel Nkwocha, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
The Role of Reprogrammed Glucose Metabolism in Cancer
Meran Keshawa Ediriweera, Sharmila Jayasena
Metabolites (2023) Vol. 13, Iss. 3, pp. 345-345
Open Access | Times Cited: 21
Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance
Lei Pan, Wenzhou Wang, Marisela Sheldon, et al.
Cancers (2023) Vol. 15, Iss. 13, pp. 3390-3390
Open Access | Times Cited: 21
Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion
Jichun Lin, Wenshuo Fang, Zhuo Xiang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 18
A Dual-Mechanism Based Nutrient Partitioning Nanoregulator for Enhanced Immunotherapy against Anti-PD-1 Resistant Tumors
Ruirui Zhang, Ruifang Li, Lan Zhang, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13461-13473
Closed Access | Times Cited: 16
New insights into the treatment of polycystic ovary syndrome: HKDC1 promotes the growth of ovarian granulocyte cells by regulating mitochondrial function and glycolysis
Peiwei Cong, Bing Shang, Lína Zhang, et al.
Journal of Molecular Histology (2024) Vol. 55, Iss. 2, pp. 187-199
Closed Access | Times Cited: 6
Epithelial-mesenchymal transition in cancer stemness and heterogeneity: updated
Keywan Mortezaee, Jamal Majidpoor, Ebrahim Kharazinejad
Medical Oncology (2022) Vol. 39, Iss. 12
Closed Access | Times Cited: 27
Energy metabolism pathways in breast cancer progression: The reprogramming, crosstalk, and potential therapeutic targets
Xuewei Zheng, Haodi Ma, Jingjing Wang, et al.
Translational Oncology (2022) Vol. 26, pp. 101534-101534
Open Access | Times Cited: 27
Molecular functions of moonlighting proteins in cell metabolic processes
Przemysław Werelusz, Sabina Galiniak, Mateusz Mołoń
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research (2023) Vol. 1871, Iss. 1, pp. 119598-119598
Open Access | Times Cited: 13
SB431542 partially inhibits high glucose-induced EMT by restoring mitochondrial homeostasis in RPE cells
Jingjing Cao, Mingfei Jiao, Zhenyu Kou, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Factors Determining Epithelial-Mesenchymal Transition in Cancer Progression
Paulina Tomecka, Dominika Kunachowicz, Julia Górczyńska, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8972-8972
Open Access | Times Cited: 4
From natural herbal wisdom to nano innovation: Revolutionizing tumor treatment through metabolic reprogramming
Zhengguang Zhang, Haitao Wu, Min Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189263-189263
Closed Access
Impaired oxidative phosphorylation drives primary tumor escape and metastasis
Emily N. Arner, Erin Q. Jennings, Daniel R. Crooks, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Carbohydrate kinase inhibition: a promising strategy in cancer treatment
Amita Jain, Rudradip Das, Monalisha Giri, et al.
Drug Discovery Today (2025), pp. 104308-104308
Closed Access
Exploring glycolytic enzymes in disease: potential biomarkers and therapeutic targets in neurodegeneration, cancer and parasitic infections
Maura Rojas-Pirela, Diego Andrade-Alviárez, Verónica Rojas, et al.
Open Biology (2025) Vol. 15, Iss. 2
Open Access
Page 1 - Next Page

Scroll to top